Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Raw Materials: 2014-2015

Historic Raw Materials for Vanda Pharmaceuticals (VNDA) over the last 2 years, with Sep 2015 value amounting to $128,000.

  • Vanda Pharmaceuticals' Raw Materials fell 39.91% to $128,000 in Q3 2015 from the same period last year, while for Sep 2015 it was $128,000, marking a year-over-year decrease of 39.91%. This contributed to the annual value of $198,000 for FY2014, which is N/A change from last year.
  • Vanda Pharmaceuticals' Raw Materials amounted to $128,000 in Q3 2015, which was down 0.00% from $128,000 recorded in Q2 2015.
  • Vanda Pharmaceuticals' Raw Materials' 5-year high stood at $213,000 during Q3 2014, with a 5-year trough of $128,000 in Q2 2015.
  • Over the past 2 years, Vanda Pharmaceuticals' median Raw Materials value was $145,000 (recorded in 2014), while the average stood at $159,571.
  • The largest annual percentage gain for Vanda Pharmaceuticals' Raw Materials in the last 5 years was 13.29% (2015), contrasted with its biggest fall of 39.91% (2015).
  • Quarterly analysis of 2 years shows Vanda Pharmaceuticals' Raw Materials stood at $198,000 in 2014, then crashed by 39.91% to $128,000 in 2015.
  • Its Raw Materials was $128,000 in Q3 2015, compared to $128,000 in Q2 2015 and $162,000 in Q1 2015.